Skip to Main content Skip to Navigation
Master Thesis

Prise en charge et prévention du mélanome cutané : rôle du pharmacien d'officine

Abstract : With 15,000 new cases and 1,700 deaths per year in France, cutaneous melanoma is the least common skin cancer, but also the most serious because of its high capacity to metastasize. Although the incidence of cutaneous melanoma is increasing, mortality is declining in women while it is stagnating in men. Many risk factors (environmental and constitutive) have been identified, with exposure to ultraviolet radiation being the main external factor. The purpose of prevention is to limit them by acting mainly on this exposure and on early detection. The rise of immunotherapy and targeted therapies have revolutionized the therapeutic care of cutaneous melanoma. Besides, over the past few years, targeted therapies are available in community pharmacy. The pharmacist, because of its accessibility, its proximity and its skills, has a leading role in the care and prevention of cutaneous melanoma. His/Her work involves dissemination of validated information on risk factors, advice on effective protective attitudes, informing patients about their care, preventing side effects of treatments, referral to supportive care, and psychological support.
Document type :
Master Thesis
Complete list of metadatas

Cited literature [110 references]  Display  Hide  Download

https://dumas.ccsd.cnrs.fr/dumas-02432468
Contributor : Ufr Santé Unicaen <>
Submitted on : Wednesday, January 8, 2020 - 2:34:53 PM
Last modification on : Friday, April 10, 2020 - 4:26:13 PM
Long-term archiving on: : Friday, April 10, 2020 - 12:25:12 AM

Identifiers

  • HAL Id : dumas-02432468, version 1

Citation

Christophe Romé. Prise en charge et prévention du mélanome cutané : rôle du pharmacien d'officine. Sciences pharmaceutiques. 2019. ⟨dumas-02432468⟩

Share

Metrics

Record views

41

Files downloads

33